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This Month in the Journal
This month in the Journal, RNA-mediated pathogenesis
is the focus of two review articles, one on myotonic
dystrophy by Laura Ranum and John Day and one on
the fragile-X premutation by Paul and Randi Hagerman.
Evidence is mounting that the expanded CUG and CCUG
repeats in DM1 and DM2 alter expression and splicing
of genes relevant to the DM phenotype by sequestering
repeat-binding proteins. The picture for the newly rec-
ognized fragile-X premutation–associated pathologies is
not as clear, although parallels with the pathogenic mech-
anism for DM are being drawn.
In conjunction with the review of the fragile-X premu-
tation, we also have a research report that focuses on
one of its associated phenotypes, the fragile-X–associ-
ated tremor/ataxia syndrome (FXTAS). Whereas previ-
ous reports found that only men are affected with this
phenotype, Hagerman et al. report ﬁve women with def-
inite or probable FXTAS.
LRP5 and Bone Phenotypes, by Ferrari et al. (p. 866)
As the song goes, short people got little noses and tiny
little teeth and wear platform shoes on their little feet.
But do they also have a missense change in LRP5? Fer-
rari et al. found variation in LRP5 that is associated with
vertebral bone size and stature, especially in adult males.
Carriers of the A allele at this exon 9 polymorphismwere,
on average, 2 cm shorter than noncarriers. In children
and adolescents, who have not reached their peak stature
and bone mass, variation at LRP5 was not strongly as-
sociated with static bone-mass and size measurements.
Instead, the exon 9 polymorphism was associated with
changes in bone mass and size over time, with carriers
of the missense variant having smaller gains in these
measurements. Again, this association was restricted to
males. This is one of the ﬁrst common genetic deter-
minants reported for vertebral bone size and stature. In
addition to its apparent role in normal growth, LRP5
has also been implicated in two syndromes characterized
by aberrant bone mass, osteoporosis pseudoglioma and
high-bone-mass syndrome.
Linkage Analysis of Bipolar Disorder with SNP
Arrays, by Middleton et al. (p. 886)
There has been a lot of recent interest in the use of SNPs,
rather than microsatellites, in genomewide linkage stud-
ies. Although, with SNPs, you lose in terms of individual
marker informativeness, you gain in terms of marker
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abundance and the ability to do high-throughput geno-
typing. Middleton et al. assess the usefulness of a SNP
genome array through comparisons with data from a mi-
crosatellite-based genome scan. The genome scans were
performed on 12 families with bipolar disorder, by use
of the GeneChip Human Mapping 10K (HMA10K) ar-
ray, which has marker spacing of ∼0.21Mb. These fami-
lies were previously included in a genome scan that used
10-cM and 4-cM microsatellite marker sets. In general,
the linkage signals from the two types of marker sets
agree, but the HMA10K array raised the linkage scores
for loci on chromosomes 6 and 11 over the level of ge-
nomewide signiﬁcance. The addition of 13 families to the
study increased the maximum nonparametric linkage
score to 4.20 on chromosome 6q22, providing further
support for a bipolar-disorder locus in this area. Sugges-
tive loci that were not picked up in the microsatellite scan
were also identiﬁed. Overall, the increased coverage and
information content of the HMA10K marker set yielded
more precise linkage information across the genome and
make it an attractive approach to consider for genome
scans.
Design and Analysis of Admixture-Mapping Studies,
by Hoggart et al. (p. 965); Dense African American
Admixture Map, by Smith et al. (p. 1001);
and High-Density Admixture Mapping, by Patterson et
al. (p. 979)
Admixture mapping exploits the fact that there are dis-
ease-causing genetic variants that differ in frequency be-
tween populations. If one looks at a population that arose
from fairly recent mixing of two or more parental popu-
lations (an admixed population), chromosomal regions
that contain a disease gene should show a higher pro-
portion of ancestry from the population with more dis-
ease-susceptibility alleles. In theory, this could be a very
useful method for mapping complex-disease loci, be-
cause it requires far fewer markers than traditional as-
sociation-mapping methods. To date, admixture map-
ping has been of more theoretical than practical sig-
niﬁcance because good tools for its use have not been
available. In this issue of the Journal, we have three
articles that go a long way toward developing admixture
mapping into a more feasible approach. Two of these,
by Hoggart et al. and by Patterson et al., focus on study
design. Between them, they evaluate and improve meth-
ods for admixture mapping and describe what they see
as the most effective designs for this approach to gene
mapping. Smith et al. present a marker map with 13,000
markers that will make possible genomewide admixture
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mapping in African Americans. The SNPs in this map
were chosen for even spacing and because of their high
allele-frequency differentiation between the African and
European parent populations. Now that an appropriate
marker map is available and analytical methods are
evolving, the real test of admixture mapping can begin:
will it actually be able to ﬁnd a disease gene?
AXIN2 in Oligodontia and Colorectal Cancer, by
Lammi et al. (p. 1043)
The Wnt signaling pathway is involved in the establish-
ment of the body axis and the development of many or-
gans. In addition, misregulation ofWnt signaling can lead
to cancer. Wnt signaling leads to accumulation of b-ca-
tenin, which facilitates expression of downstream targets.
Without a Wnt signal, b-catenin is phosphorylated and
subsequently degraded through the action of a protein
complex that includes APC, Axin1, and Axin2. This com-
plex therefore serves as a negative regulator of Wnt sig-
naling. Lammi et al. report a truncating AXIN2mutation
in a family segregating a phenotypewith two components:
oligodontia, the congenital lack of several permanent
teeth, and colorectal neoplasia. A second truncating
AXIN2 mutation was found in an isolated subject with
oligodontia. Both mutations are predicted to cause loss
of function and, therefore, increasedWnt signaling. These
data suggest that overstimulation of the Wnt pathway
leads to failure of the development of permanent but not
baby teeth. It had already been reported that somatic
mutations in components of the b-catenin degradation
complex can be found in various cancers. Perhaps the
surprising thing, then, is that the phenotype in the affected
individuals reported by Lammi et al. is limited to the teeth
and colon, since Wnt signaling is so widely used in the
regulation of development and homeostasis. This might
give us a clue as to where and when regulation of Wnt
signaling by AXIN2 is important.
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